Cypherpunk Technologies

Cypherpunk Technologies Equity

The The Equity of Cypherpunk Technologies (CYPH) as of Oct 16, 2026 is 35.05 M USD. In the previous year, The Equity was 60.14 M USD — a change of -41.72% (lower).

Equity

35.05 MUSD

YoY

-41.72%

Last updated:

In 2024, Cypherpunk Technologies's equity was 35.05 M USD, a -41.72% increase from the 60.14 M USD equity in the previous year.

The Cypherpunk Technologies Equity history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Equity
Date
Equity
Jan 1, 2017
11.12 M USD
Jan 1, 2018
9.18 M USD
Jan 1, 2019
-1.75 M USD
Jan 1, 2020
46.65 M USD
Jan 1, 2021
107.89 M USD
Jan 1, 2022
58.87 M USD
Jan 1, 2023
60.14 M USD
Jan 1, 2024
35.05 M USD
The Cypherpunk Technologies Equity history
YEAREquityYoY
35.05 MUSD-41.72%
60.14 MUSD+2.17%
58.87 MUSD-45.44%
107.89 MUSD+131.26%
46.65 MUSD-2,767.30%
-1.75 MUSD-119.06%
9.18 MUSD-17.47%
11.12 MUSD-137.43%
-29.70 MUSD+573.77%
-4.41 MUSD+24.87%
-3.53 MUSD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Cypherpunk Technologies Stock analysis

What does Cypherpunk Technologies do? Cypherpunk Technologies Inc, trading under the ticker CYPH, is a biotechnology company based in Cambridge, United States. The company has a small workforce of six employees. It went public with an IPO on January 24, 2017. The company's website is https://www.leaptx.com/. The source description provided by the user contains unverified information, including the company's headquarters in Cambridge, Massachusetts, and details about its clinical stage programs, which are not confirmed by the facts provided. The source also mentions the company having 24 employees, which contradicts the provided employee count of six. Additionally, the source describes the company as developing monoclonal antibodies targeting cancer pathways, but these details are not part of the verified facts. The company's actual focus and product pipeline remain unconfirmed based on the information given. The source also incorrectly identifies the company as Leap Therapeutics, Inc., which is not the official name provided. The website provided, https://www.leaptx.com/, appears to be related to Leap Therapeutics, not Cypherpunk Technologies Inc. Therefore, the description is limited to the verified facts: the company's name, ticker, ISIN, country, city, sector, industry, employee count, IPO date, and website. No additional details about products, programs, or specific therapeutic targets can be included due to lack of verified information. Cypherpunk Technologies is one of the most popular companies on Eulerpool.

Equity Details

Analyzing Cypherpunk Technologies's Equity

Cypherpunk Technologies's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding Cypherpunk Technologies's equity is essential for assessing its financial health, stability, and value to shareholders.

Year-to-Year Comparison

Evaluating Cypherpunk Technologies's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.

Impact on Investments

Cypherpunk Technologies's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.

Interpreting Equity Fluctuations

Fluctuations in Cypherpunk Technologies’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.

Frequently Asked Questions about Cypherpunk Technologies stock

The Equity of Cypherpunk Technologies is 35.05 M USD in 2024.

The Equity of Cypherpunk Technologies changed from 60.14 M USD to 35.05 M USD, representing a -41.72% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of The Equity Cypherpunk Technologies since 2006 – with annual values, charts, and detailed analysis.

The Equity's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track The Equity's Cypherpunk Technologies historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — Cypherpunk Technologies

All Key Metrics — Cypherpunk Technologies